The company’s mission is to improve the lives of people with bladder health problems by providing them with personalized care and support.
Jude, a London-based startup focused on bladder health, has secured $4.24 million in a seed funding round. The capital will be used to support the company’s expansion into the US market, as well as the development of new services and products.
Jude was founded in 2022 by Peony Li, who herself has suffered from chronic bladder infections since she was a child. The company’s mission is to improve the lives of people with bladder health problems by providing them with personalized care and support.
Jude’s services include a range of digital tools, such as symptom tracking and medication reminders, as well as access to a team of healthcare professionals. The company also offers a range of natural treatments for bladder health problems.
The funding round was led by Eka VC and Joyance, with participation from June Angelides at Samos VC and Dr. Fiona Pathiraja of Crista Galli Ventures. A grant from Innovate UK was also given to Jude.
With the new funding, Jude plans to expand its services into the US market by the end of the year. The company also plans to develop new services and products, such as a prescription service and a line of nutritional supplements.
“We are excited to use this funding to help more people with bladder health problems,” said Peony Li, CEO of Jude. “We believe that everyone deserves to live a healthy and fulfilling life, regardless of their bladder health.”
The global market for bladder health is worth an estimated $40 billion. Jude is well-positioned to capitalize on this market, as it is one of the few companies that offers a holistic approach to bladder health. The company’s personalized care and support are also likely to appeal to patients who have been struggling to find relief from their bladder problems.
The funding round is a significant milestone for Jude, and it will help the company to achieve its mission of improving the lives of people with bladder health problems.